Salome Mekhuzla/LinkedIn
Oct 17, 2025, 08:37
Salome Mekhuzla Invites You to Join WHO Essential Medicines List 2025 Updates Webinar on Hemophilia and VWD
Salome Mekhuzla, Director of Global Development at the World Federation of Hemophilia, reposted from WFH on LinkedIn:
”Join us tomorrow to learn about the WHO Essential Medicines List 2025 updates in relation to treatment of hemophilia and vWD and what impact these critical changes could have on treatment access.”
Quoting WFH‘s post:
”Don’t miss tomorrow’s webinar WFH informational webinar on the recent milestone revisions to the WHO Essential Medicines List (EMLs)!
Hear about the advocacy efforts led by the WFH and partners, the key updates to the EMLs, and what these changes mean in practice for our community.
Register now.”
Stay updated with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis